The difference in safety events between the 2 groups did not reach statistical significance, regardless of whether variables were adjusted (Table 2 ).
← all excerpts
Effect of Argatroban Plus Dual Antiplatelet in Branch Atherosclerosis Disease: A Randomized Clinical Trial.
1
—
—